Surat Pharmaceuticals Private Limited
About Surat Pharmaceuticals Private Limited
Data last updated:
Surat Pharmaceuticals Private Limited is a private limited company based in Bhilai, Chhattisgarh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U51909CT2018PTC008933. Its GSTIN is 22ABBCS2177D1ZR (Chhattisgarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pushpa Tiwari and Tushar Tiwari.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar (West), Bhilai, Chhattisgarh, India – 490001.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.44 Lakh, a growth of 95% compared to the previous year. For the same year it recorded a net loss of ₹2.05 Lakh (net margin -27.6%) and EBITDA of -₹1.97 Lakh (EBITDA margin -26.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBlock No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar (West), Bhilai, Chhattisgarh, India – 490001
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Surat Pharmaceuticals Private Limited
The main business activity of Surat Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Surat Pharmaceuticals Private Limited FY 2025 filings available
Surat Pharmaceuticals Private Limited reported revenue of ₹7.44 Lakh (up 95% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Surat Pharmaceuticals Private Limited
Revenue rose 95% in the latest year. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Surat Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.97 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Surat Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -26.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -27.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Surat Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpa Tiwari | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Tushar Tiwari | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
Peer Comparison of Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meditech Human Pharmaceuticals Private Limited | ₹7.5 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Mumbai, Maharashtra, India |
| Safna Pharmaceuticals Private Limited | ₹7.5 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Wellisto Pharmaceuticals Private Limited | ₹7.49 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Pune, Maharashtra, India |
| Healthedge Pharmaceuticals Private Limited | ₹7.49 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Ahmedabad, Gujarat, India |
| Aristocrat Pharmaceuticals Private Limited | ₹7.44 Lakh (FY 2024) | •••• | •••• | -35.0% | •••• | Gurugram, Haryana, India |
| Surat Pharmaceuticals Private Limited this company | ₹7.44 Lakh (FY 2025) | •••• | •••• | 95.0% | •••• | Bhilai, Chhattisgarh, India |
| Alger Pharmaceuticals Private Limited | ₹7.43 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Barrex Pharmaceuticals Private Limited | ₹7.43 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Angaj Pharmaceuticals Private Limited | ₹7.4 Lakh (FY 2025) | •••• | •••• | 92.0% | •••• | Sangli, Maharashtra, India |
| Shellcure Pharmaceuticals Private Limited | ₹7.4 Lakh (FY 2020) | •••• | •••• | -7.0% | •••• | Pune, Maharashtra, India |
| Asbed Pharmaceuticals Private Limited | ₹7.39 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Maninagar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Surat Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Surat Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Surat Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Surat Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pushpa Tiwari was appointed as Director on 03 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Surat Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Surat Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Surat Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22ABBCS2177D1ZR | Chhattisgarh | Active | 29 Apr 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Surat Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals is an active private limited company based in Bhilai, Chhattisgarh, India. The company works in specialty, within the trading industry. It was incorporated on 03 December 2018 (8+ years old) and is registered under CIN U51909CT2018PTC008933.
Surat Pharmaceuticals reported revenue of ₹7.44 Lakh for FY 2025 (up 95% YoY).
Surat Pharmaceuticals has 2 current directors:
- Pushpa Tiwari - Director
- Tushar Tiwari - Director
Surat Pharmaceuticals reported a net loss of ₹2.05 Lakh (net margin -27.6%) and EBITDA of -₹1.97 Lakh (EBITDA margin -26.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Surat Pharmaceuticals is 22ABBCS2177D1ZR, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Surat Pharmaceuticals is U51909CT2018PTC008933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surat Pharmaceuticals was incorporated on 03 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Surat Pharmaceuticals by revenue are Meditech Human Pharmaceuticals Private Limited, Safna Pharmaceuticals Private Limited, Wellisto Pharmaceuticals Private Limited, Healthedge Pharmaceuticals Private Limited, Aristocrat Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Pushpa Tiwari was appointed as Director on 03 Dec 2018. Tushar Tiwari was appointed as Director on 03 Dec 2018.
The registered office of Surat Pharmaceuticals is at Block No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar West, Bhilai, Chhattisgarh, India – 490001.
Surat Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.